nodes	percent_of_prediction	percent_of_DWPC	metapath
Norepinephrine—L-DOPA—Liothyronine—hypothyroidism	0.743	1	CrCrCtD
Norepinephrine—ADRB3—brown adipose tissue—hypothyroidism	0.0168	0.197	CbGeAlD
Norepinephrine—POU5F1—cerebellum—hypothyroidism	0.00749	0.0877	CbGeAlD
Norepinephrine—Arrhythmia—Liothyronine—hypothyroidism	0.00449	0.0929	CcSEcCtD
Norepinephrine—Extravasation—Liotrix—hypothyroidism	0.00415	0.0858	CcSEcCtD
Norepinephrine—Hypertension—Liothyronine—hypothyroidism	0.00378	0.0782	CcSEcCtD
Norepinephrine—SLC18A1—adrenal gland—hypothyroidism	0.00363	0.0425	CbGeAlD
Norepinephrine—SLC22A3—tongue—hypothyroidism	0.00291	0.0341	CbGeAlD
Norepinephrine—CYP1A2—urine—hypothyroidism	0.00284	0.0333	CbGeAlD
Norepinephrine—Sweating—Dextrothyroxine—hypothyroidism	0.00264	0.0545	CcSEcCtD
Norepinephrine—Sweating—Levothyroxine—hypothyroidism	0.00264	0.0545	CcSEcCtD
Norepinephrine—PAH—blood—hypothyroidism	0.0026	0.0305	CbGeAlD
Norepinephrine—SLC6A2—nerve—hypothyroidism	0.00255	0.0299	CbGeAlD
Norepinephrine—DRD2—nerve—hypothyroidism	0.00233	0.0272	CbGeAlD
Norepinephrine—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00221	0.0456	CcSEcCtD
Norepinephrine—Arrhythmia—Levothyroxine—hypothyroidism	0.00221	0.0456	CcSEcCtD
Norepinephrine—PAH—liver—hypothyroidism	0.00204	0.0238	CbGeAlD
Norepinephrine—Sweating—Liotrix—hypothyroidism	0.00194	0.0401	CcSEcCtD
Norepinephrine—ADRB3—female gonad—hypothyroidism	0.0019	0.0222	CbGeAlD
Norepinephrine—Anxiety—Levothyroxine—hypothyroidism	0.00182	0.0377	CcSEcCtD
Norepinephrine—Anxiety—Dextrothyroxine—hypothyroidism	0.00182	0.0377	CcSEcCtD
Norepinephrine—Hyperhidrosis—Levothyroxine—hypothyroidism	0.0017	0.0351	CcSEcCtD
Norepinephrine—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.0017	0.0351	CcSEcCtD
Norepinephrine—Arrhythmia—Liotrix—hypothyroidism	0.00162	0.0336	CcSEcCtD
Norepinephrine—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00156	0.0324	CcSEcCtD
Norepinephrine—Dyspnoea—Levothyroxine—hypothyroidism	0.00156	0.0324	CcSEcCtD
Norepinephrine—Hypertension—Liotrix—hypothyroidism	0.00137	0.0282	CcSEcCtD
Norepinephrine—Chest pain—Liotrix—hypothyroidism	0.00135	0.0278	CcSEcCtD
Norepinephrine—Anxiety—Liotrix—hypothyroidism	0.00134	0.0277	CcSEcCtD
Norepinephrine—Hyperhidrosis—Liotrix—hypothyroidism	0.00125	0.0258	CcSEcCtD
Norepinephrine—SLC18A2—adrenal gland—hypothyroidism	0.00116	0.0136	CbGeAlD
Norepinephrine—SLC18A2—blood—hypothyroidism	0.00116	0.0136	CbGeAlD
Norepinephrine—Dyspnoea—Liotrix—hypothyroidism	0.00115	0.0238	CcSEcCtD
Norepinephrine—SLC18A2—thyroid gland—hypothyroidism	0.00112	0.0131	CbGeAlD
Norepinephrine—Vomiting—Levothyroxine—hypothyroidism	0.00112	0.0231	CcSEcCtD
Norepinephrine—Vomiting—Dextrothyroxine—hypothyroidism	0.00112	0.0231	CcSEcCtD
Norepinephrine—ADRB1—heart—hypothyroidism	0.00111	0.0131	CbGeAlD
Norepinephrine—Headache—Dextrothyroxine—hypothyroidism	0.0011	0.0227	CcSEcCtD
Norepinephrine—Headache—Levothyroxine—hypothyroidism	0.0011	0.0227	CcSEcCtD
Norepinephrine—ADRB1—cardiovascular system—hypothyroidism	0.00105	0.0123	CbGeAlD
Norepinephrine—SLC18A2—testis—hypothyroidism	0.000959	0.0112	CbGeAlD
Norepinephrine—SLC22A3—gonad—hypothyroidism	0.000947	0.0111	CbGeAlD
Norepinephrine—SLC18A2—liver—hypothyroidism	0.000907	0.0106	CbGeAlD
Norepinephrine—SLC18A2—cerebellum—hypothyroidism	0.000886	0.0104	CbGeAlD
Norepinephrine—ADRA1A—heart—hypothyroidism	0.000881	0.0103	CbGeAlD
Norepinephrine—ADRA2C—adrenal cortex—hypothyroidism	0.000868	0.0102	CbGeAlD
Norepinephrine—SLC22A1—blood—hypothyroidism	0.000864	0.0101	CbGeAlD
Norepinephrine—ADRA2C—heart—hypothyroidism	0.00084	0.00983	CbGeAlD
Norepinephrine—SLC22A5—adrenal cortex—hypothyroidism	0.000832	0.00974	CbGeAlD
Norepinephrine—ADRA1A—cardiovascular system—hypothyroidism	0.000832	0.00974	CbGeAlD
Norepinephrine—SLC22A3—adrenal gland—hypothyroidism	0.000826	0.00967	CbGeAlD
Norepinephrine—Vomiting—Liotrix—hypothyroidism	0.000821	0.017	CcSEcCtD
Norepinephrine—SLC6A2—gonad—hypothyroidism	0.000812	0.00951	CbGeAlD
Norepinephrine—Headache—Liotrix—hypothyroidism	0.000809	0.0167	CcSEcCtD
Norepinephrine—SLC22A5—heart—hypothyroidism	0.000804	0.00942	CbGeAlD
Norepinephrine—SLC22A3—thyroid gland—hypothyroidism	0.000797	0.00933	CbGeAlD
Norepinephrine—SLC22A3—female gonad—hypothyroidism	0.00077	0.00902	CbGeAlD
Norepinephrine—DRD2—pituitary gland—hypothyroidism	0.000722	0.00845	CbGeAlD
Norepinephrine—SLC6A2—adrenal gland—hypothyroidism	0.000708	0.00828	CbGeAlD
Norepinephrine—ADRA2C—pituitary gland—hypothyroidism	0.000702	0.00822	CbGeAlD
Norepinephrine—SLC22A3—testis—hypothyroidism	0.000683	0.008	CbGeAlD
Norepinephrine—SLC22A1—liver—hypothyroidism	0.000676	0.00791	CbGeAlD
Norepinephrine—SLC22A5—pituitary gland—hypothyroidism	0.000672	0.00787	CbGeAlD
Norepinephrine—ADRA2A—heart—hypothyroidism	0.00067	0.00785	CbGeAlD
Norepinephrine—ADRA1A—adrenal gland—hypothyroidism	0.000658	0.0077	CbGeAlD
Norepinephrine—ADRA1A—blood—hypothyroidism	0.000658	0.0077	CbGeAlD
Norepinephrine—SLC22A3—liver—hypothyroidism	0.000646	0.00756	CbGeAlD
Norepinephrine—ADRA2C—adrenal gland—hypothyroidism	0.000627	0.00734	CbGeAlD
Norepinephrine—ADRA2C—blood—hypothyroidism	0.000627	0.00734	CbGeAlD
Norepinephrine—SLC22A5—adrenal gland—hypothyroidism	0.0006	0.00703	CbGeAlD
Norepinephrine—SLC22A5—blood—hypothyroidism	0.0006	0.00703	CbGeAlD
Norepinephrine—SLC6A2—testis—hypothyroidism	0.000585	0.00685	CbGeAlD
Norepinephrine—ADRA2C—female gonad—hypothyroidism	0.000584	0.00684	CbGeAlD
Norepinephrine—SLC22A5—thyroid gland—hypothyroidism	0.000579	0.00678	CbGeAlD
Norepinephrine—ADRA2A—gonad—hypothyroidism	0.000574	0.00672	CbGeAlD
Norepinephrine—ADRA2A—pituitary gland—hypothyroidism	0.00056	0.00656	CbGeAlD
Norepinephrine—SLC22A5—female gonad—hypothyroidism	0.00056	0.00656	CbGeAlD
Norepinephrine—CYP1A2—blood—hypothyroidism	0.000544	0.00637	CbGeAlD
Norepinephrine—DRD2—testis—hypothyroidism	0.000533	0.00624	CbGeAlD
Norepinephrine—CYP1A2—thyroid gland—hypothyroidism	0.000525	0.00615	CbGeAlD
Norepinephrine—ADRA2C—testis—hypothyroidism	0.000518	0.00607	CbGeAlD
Norepinephrine—ADRA1A—liver—hypothyroidism	0.000514	0.00602	CbGeAlD
Norepinephrine—ADRA1A—cerebellum—hypothyroidism	0.000502	0.00588	CbGeAlD
Norepinephrine—ADRA2A—adrenal gland—hypothyroidism	0.0005	0.00586	CbGeAlD
Norepinephrine—ADRA2A—blood—hypothyroidism	0.0005	0.00586	CbGeAlD
Norepinephrine—SLC22A5—testis—hypothyroidism	0.000497	0.00581	CbGeAlD
Norepinephrine—DRD2—cerebellum—hypothyroidism	0.000492	0.00577	CbGeAlD
Norepinephrine—ADRA2C—liver—hypothyroidism	0.00049	0.00574	CbGeAlD
Norepinephrine—ADRA2A—thyroid gland—hypothyroidism	0.000483	0.00565	CbGeAlD
Norepinephrine—ADRA2C—cerebellum—hypothyroidism	0.000479	0.00561	CbGeAlD
Norepinephrine—SLC22A5—liver—hypothyroidism	0.000469	0.0055	CbGeAlD
Norepinephrine—ADRA2A—female gonad—hypothyroidism	0.000466	0.00546	CbGeAlD
Norepinephrine—SLC22A5—cerebellum—hypothyroidism	0.000459	0.00537	CbGeAlD
Norepinephrine—CYP1A2—liver—hypothyroidism	0.000425	0.00498	CbGeAlD
Norepinephrine—ADRA2A—testis—hypothyroidism	0.000414	0.00484	CbGeAlD
Norepinephrine—ADRA2A—cerebellum—hypothyroidism	0.000382	0.00447	CbGeAlD
Norepinephrine—ADRA2C—Signaling by GPCR—TRH—hypothyroidism	6.08e-05	0.000493	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—TRH—hypothyroidism	6.08e-05	0.000492	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—VAV3—hypothyroidism	6.04e-05	0.000489	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—TRH—hypothyroidism	5.99e-05	0.000485	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—TSHR—hypothyroidism	5.97e-05	0.000483	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—TSHB—hypothyroidism	5.97e-05	0.000483	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—TSHB—hypothyroidism	5.88e-05	0.000476	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—TSHR—hypothyroidism	5.88e-05	0.000476	CbGpPWpGaD
Norepinephrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	5.87e-05	0.000475	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	5.87e-05	0.000475	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—TSHB—hypothyroidism	5.86e-05	0.000474	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—TSHR—hypothyroidism	5.86e-05	0.000474	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—TRH—hypothyroidism	5.85e-05	0.000474	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TSHB—hypothyroidism	5.83e-05	0.000472	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—TSHR—hypothyroidism	5.83e-05	0.000472	CbGpPWpGaD
Norepinephrine—ADRA2B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	5.82e-05	0.000471	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—AVP—hypothyroidism	5.82e-05	0.000471	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—TSHB—hypothyroidism	5.8e-05	0.00047	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—TSHR—hypothyroidism	5.8e-05	0.00047	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—VAV3—hypothyroidism	5.78e-05	0.000468	CbGpPWpGaD
Norepinephrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	5.74e-05	0.000465	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—TSHB—hypothyroidism	5.73e-05	0.000464	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—TSHR—hypothyroidism	5.73e-05	0.000464	CbGpPWpGaD
Norepinephrine—DRD2—GPCR ligand binding—AVP—hypothyroidism	5.65e-05	0.000458	CbGpPWpGaD
Norepinephrine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	5.61e-05	0.000454	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—PIK3C2A—hypothyroidism	5.6e-05	0.000453	CbGpPWpGaD
Norepinephrine—ADRA2A—G alpha (i) signalling events—POMC—hypothyroidism	5.55e-05	0.000449	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—TRH—hypothyroidism	5.52e-05	0.000447	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—AVP—hypothyroidism	5.44e-05	0.000441	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—TRH—hypothyroidism	5.44e-05	0.000441	CbGpPWpGaD
Norepinephrine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	5.43e-05	0.00044	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—TSHB—hypothyroidism	5.42e-05	0.000439	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—TSHR—hypothyroidism	5.42e-05	0.000439	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	5.42e-05	0.000439	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	5.42e-05	0.000439	CbGpPWpGaD
Norepinephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	5.35e-05	0.000433	CbGpPWpGaD
Norepinephrine—PAH—Metabolism—POMC—hypothyroidism	5.34e-05	0.000432	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—TSHB—hypothyroidism	5.34e-05	0.000432	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—TSHR—hypothyroidism	5.34e-05	0.000432	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—TRH—hypothyroidism	5.32e-05	0.000431	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—TSHB—hypothyroidism	5.22e-05	0.000423	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—TSHR—hypothyroidism	5.22e-05	0.000423	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—SH2B3—hypothyroidism	5.2e-05	0.000421	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—AVP—hypothyroidism	5.06e-05	0.00041	CbGpPWpGaD
Norepinephrine—SLC22A2—Transmembrane transport of small molecules—AVP—hypothyroidism	4.95e-05	0.000401	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—TRH—hypothyroidism	4.94e-05	0.0004	CbGpPWpGaD
Norepinephrine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.93e-05	0.000399	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—CLTC—hypothyroidism	4.93e-05	0.000399	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—TSHB—hypothyroidism	4.92e-05	0.000398	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—TSHR—hypothyroidism	4.92e-05	0.000398	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR ligand binding—POMC—hypothyroidism	4.91e-05	0.000397	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—TSHB—hypothyroidism	4.85e-05	0.000393	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—TSHR—hypothyroidism	4.85e-05	0.000393	CbGpPWpGaD
Norepinephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.75e-05	0.000385	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—TSHB—hypothyroidism	4.74e-05	0.000384	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—TSHR—hypothyroidism	4.74e-05	0.000384	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—SLC5A5—hypothyroidism	4.7e-05	0.000381	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—VAV3—hypothyroidism	4.69e-05	0.00038	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—IYD—hypothyroidism	4.64e-05	0.000376	CbGpPWpGaD
Norepinephrine—SLC22A1—Transmembrane transport of small molecules—AVP—hypothyroidism	4.62e-05	0.000374	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—CLTC—hypothyroidism	4.49e-05	0.000364	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR ligand binding—POMC—hypothyroidism	4.47e-05	0.000362	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—CLTC—hypothyroidism	4.45e-05	0.00036	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR ligand binding—POMC—hypothyroidism	4.43e-05	0.000359	CbGpPWpGaD
Norepinephrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	4.41e-05	0.000357	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—TSHB—hypothyroidism	4.4e-05	0.000357	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—TSHR—hypothyroidism	4.4e-05	0.000357	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—CLTC—hypothyroidism	4.39e-05	0.000356	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR ligand binding—POMC—hypothyroidism	4.37e-05	0.000354	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—VAV3—hypothyroidism	4.33e-05	0.000351	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TRH—hypothyroidism	4.26e-05	0.000345	CbGpPWpGaD
Norepinephrine—ADRB3—GPCR downstream signaling—POMC—hypothyroidism	4.26e-05	0.000345	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—AVP—hypothyroidism	4.17e-05	0.000338	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—CLTC—hypothyroidism	4.16e-05	0.000337	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR ligand binding—POMC—hypothyroidism	4.14e-05	0.000335	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—CLTC—hypothyroidism	4.09e-05	0.000331	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR ligand binding—POMC—hypothyroidism	4.07e-05	0.00033	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—VAV3—hypothyroidism	3.95e-05	0.00032	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—ATP5O—hypothyroidism	3.95e-05	0.00032	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—TSHB—hypothyroidism	3.94e-05	0.000319	CbGpPWpGaD
Norepinephrine—CYP1A2—Biological oxidations—POMC—hypothyroidism	3.93e-05	0.000319	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—VAV3—hypothyroidism	3.93e-05	0.000318	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—VAV3—hypothyroidism	3.91e-05	0.000317	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TRH—hypothyroidism	3.88e-05	0.000314	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling by GPCR—POMC—hypothyroidism	3.86e-05	0.000313	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—VAV3—hypothyroidism	3.86e-05	0.000313	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—PRL—hypothyroidism	3.85e-05	0.000312	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TRH—hypothyroidism	3.85e-05	0.000312	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—TSHB—hypothyroidism	3.83e-05	0.00031	CbGpPWpGaD
Norepinephrine—ADRA2B—Hemostasis—IGF1—hypothyroidism	3.81e-05	0.000309	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—AVP—hypothyroidism	3.8e-05	0.000308	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TSHB—hypothyroidism	3.8e-05	0.000308	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—TSHR—hypothyroidism	3.8e-05	0.000308	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TRH—hypothyroidism	3.8e-05	0.000308	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—AVP—hypothyroidism	3.79e-05	0.000307	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—CLTC—hypothyroidism	3.77e-05	0.000305	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—AVP—hypothyroidism	3.77e-05	0.000305	CbGpPWpGaD
Norepinephrine—DRD2—GPCR ligand binding—POMC—hypothyroidism	3.75e-05	0.000304	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—AVP—hypothyroidism	3.72e-05	0.000301	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—TPO—hypothyroidism	3.71e-05	0.0003	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—TSHB—hypothyroidism	3.67e-05	0.000297	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—VAV3—hypothyroidism	3.65e-05	0.000296	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—CLTC—hypothyroidism	3.63e-05	0.000294	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR ligand binding—POMC—hypothyroidism	3.62e-05	0.000293	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—VAV3—hypothyroidism	3.59e-05	0.000291	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TRH—hypothyroidism	3.59e-05	0.000291	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—VAV3—hypothyroidism	3.58e-05	0.00029	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—VAV3—hypothyroidism	3.57e-05	0.000289	CbGpPWpGaD
Norepinephrine—ADRA2C—Hemostasis—IGF1—hypothyroidism	3.56e-05	0.000288	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—VAV3—hypothyroidism	3.55e-05	0.000288	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TRH—hypothyroidism	3.54e-05	0.000286	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—AVP—hypothyroidism	3.52e-05	0.000285	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—PIK3C2A—hypothyroidism	3.51e-05	0.000284	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—VAV3—hypothyroidism	3.5e-05	0.000284	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—AVP—hypothyroidism	3.46e-05	0.00028	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TSHR—hypothyroidism	3.46e-05	0.00028	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—TSHB—hypothyroidism	3.46e-05	0.00028	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—AVP—hypothyroidism	3.45e-05	0.00028	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	3.44e-05	0.000278	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—AVP—hypothyroidism	3.44e-05	0.000278	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TSHB—hypothyroidism	3.43e-05	0.000278	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—TSHR—hypothyroidism	3.43e-05	0.000278	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—AVP—hypothyroidism	3.42e-05	0.000277	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—PIK3C2A—hypothyroidism	3.41e-05	0.000276	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—SH2B3—hypothyroidism	3.38e-05	0.000274	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TSHB—hypothyroidism	3.38e-05	0.000274	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—TSHR—hypothyroidism	3.38e-05	0.000274	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—AVP—hypothyroidism	3.38e-05	0.000273	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—CLTC—hypothyroidism	3.38e-05	0.000273	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR ligand binding—POMC—hypothyroidism	3.36e-05	0.000272	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—VAV3—hypothyroidism	3.32e-05	0.000269	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	3.31e-05	0.000268	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—PIK3C2A—hypothyroidism	3.27e-05	0.000265	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—VAV3—hypothyroidism	3.26e-05	0.000264	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TRH—hypothyroidism	3.26e-05	0.000264	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TSHB—hypothyroidism	3.2e-05	0.000259	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—TSHR—hypothyroidism	3.2e-05	0.000259	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—AVP—hypothyroidism	3.19e-05	0.000259	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—AVP—hypothyroidism	3.19e-05	0.000259	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—VAV3—hypothyroidism	3.19e-05	0.000259	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TSHB—hypothyroidism	3.15e-05	0.000255	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—TSHR—hypothyroidism	3.15e-05	0.000255	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—AVP—hypothyroidism	3.14e-05	0.000255	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TRH—hypothyroidism	3.14e-05	0.000254	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—TSHB—hypothyroidism	3.11e-05	0.000252	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—SH2B3—hypothyroidism	3.08e-05	0.00025	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—AVP—hypothyroidism	3.08e-05	0.000249	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—SH2B3—hypothyroidism	3.06e-05	0.000247	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—SH2B3—hypothyroidism	3.02e-05	0.000244	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—VAV3—hypothyroidism	3.01e-05	0.000244	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—VAV3—hypothyroidism	2.97e-05	0.00024	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—SLC5A5—hypothyroidism	2.95e-05	0.000239	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TRH—hypothyroidism	2.92e-05	0.000236	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TSHB—hypothyroidism	2.91e-05	0.000235	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—TSHR—hypothyroidism	2.91e-05	0.000235	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—AVP—hypothyroidism	2.9e-05	0.000235	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—VAV3—hypothyroidism	2.9e-05	0.000235	CbGpPWpGaD
Norepinephrine—ADRA2A—Hemostasis—IGF1—hypothyroidism	2.89e-05	0.000234	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—SLC5A5—hypothyroidism	2.87e-05	0.000232	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—AVP—hypothyroidism	2.86e-05	0.000231	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—SH2B3—hypothyroidism	2.85e-05	0.000231	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—SH2B3—hypothyroidism	2.81e-05	0.000228	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TSHR—hypothyroidism	2.8e-05	0.000227	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—TSHB—hypothyroidism	2.8e-05	0.000227	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—AVP—hypothyroidism	2.79e-05	0.000226	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—PIK3C2A—hypothyroidism	2.77e-05	0.000225	CbGpPWpGaD
Norepinephrine—ADRA1D—GPCR downstream signaling—POMC—hypothyroidism	2.77e-05	0.000225	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—SLC5A5—hypothyroidism	2.75e-05	0.000222	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—VAV3—hypothyroidism	2.69e-05	0.000218	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TSHB—hypothyroidism	2.6e-05	0.000211	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—TSHR—hypothyroidism	2.6e-05	0.000211	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—AVP—hypothyroidism	2.6e-05	0.00021	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—SH2B3—hypothyroidism	2.59e-05	0.00021	CbGpPWpGaD
Norepinephrine—ADRB1—GPCR downstream signaling—POMC—hypothyroidism	2.53e-05	0.000205	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling by GPCR—POMC—hypothyroidism	2.52e-05	0.000204	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—PRL—hypothyroidism	2.51e-05	0.000203	CbGpPWpGaD
Norepinephrine—ADRA2B—GPCR downstream signaling—POMC—hypothyroidism	2.5e-05	0.000203	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—SH2B3—hypothyroidism	2.5e-05	0.000202	CbGpPWpGaD
Norepinephrine—ADRB2—GPCR downstream signaling—POMC—hypothyroidism	2.47e-05	0.0002	CbGpPWpGaD
Norepinephrine—SLC22A3—Metabolism—POMC—hypothyroidism	2.46e-05	0.000199	CbGpPWpGaD
Norepinephrine—ADRA2C—GPCR downstream signaling—POMC—hypothyroidism	2.34e-05	0.000189	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—SLC5A5—hypothyroidism	2.33e-05	0.000189	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—VAV3—hypothyroidism	2.32e-05	0.000188	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—SH2B3—hypothyroidism	2.32e-05	0.000188	CbGpPWpGaD
Norepinephrine—ADRA1B—GPCR downstream signaling—POMC—hypothyroidism	2.3e-05	0.000186	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling by GPCR—POMC—hypothyroidism	2.29e-05	0.000186	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—PRL—hypothyroidism	2.29e-05	0.000185	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—POMC—hypothyroidism	2.28e-05	0.000185	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling by GPCR—POMC—hypothyroidism	2.27e-05	0.000184	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—PRL—hypothyroidism	2.27e-05	0.000184	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling by GPCR—POMC—hypothyroidism	2.24e-05	0.000182	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—AVP—hypothyroidism	2.24e-05	0.000181	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—PRL—hypothyroidism	2.24e-05	0.000181	CbGpPWpGaD
Norepinephrine—ADRB3—Signaling Pathways—IGF1—hypothyroidism	2.2e-05	0.000178	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling by GPCR—POMC—hypothyroidism	2.12e-05	0.000172	CbGpPWpGaD
Norepinephrine—DRD2—GPCR downstream signaling—POMC—hypothyroidism	2.12e-05	0.000172	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—PRL—hypothyroidism	2.12e-05	0.000171	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—VAV3—hypothyroidism	2.12e-05	0.000171	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—VAV3—hypothyroidism	2.1e-05	0.00017	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling by GPCR—POMC—hypothyroidism	2.09e-05	0.000169	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—PRL—hypothyroidism	2.08e-05	0.000169	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—VAV3—hypothyroidism	2.07e-05	0.000168	CbGpPWpGaD
Norepinephrine—ADRA1A—GPCR downstream signaling—POMC—hypothyroidism	2.04e-05	0.000166	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—AVP—hypothyroidism	2.04e-05	0.000165	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—AVP—hypothyroidism	2.02e-05	0.000164	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—AVP—hypothyroidism	1.99e-05	0.000162	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—VAV3—hypothyroidism	1.96e-05	0.000159	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—VAV3—hypothyroidism	1.93e-05	0.000156	CbGpPWpGaD
Norepinephrine—DRD2—Signaling by GPCR—POMC—hypothyroidism	1.93e-05	0.000156	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—PRL—hypothyroidism	1.92e-05	0.000156	CbGpPWpGaD
Norepinephrine—ADRA2A—GPCR downstream signaling—POMC—hypothyroidism	1.9e-05	0.000154	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—AVP—hypothyroidism	1.89e-05	0.000153	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—AVP—hypothyroidism	1.86e-05	0.00015	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling by GPCR—POMC—hypothyroidism	1.86e-05	0.00015	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—PRL—hypothyroidism	1.85e-05	0.00015	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—VAV3—hypothyroidism	1.78e-05	0.000144	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling by GPCR—POMC—hypothyroidism	1.72e-05	0.00014	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—PRL—hypothyroidism	1.72e-05	0.000139	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—TSHB—hypothyroidism	1.72e-05	0.000139	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—AVP—hypothyroidism	1.71e-05	0.000139	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—VAV3—hypothyroidism	1.71e-05	0.000139	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—AVP—hypothyroidism	1.65e-05	0.000134	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—VAV3—hypothyroidism	1.59e-05	0.000129	CbGpPWpGaD
Norepinephrine—SLC22A2—Metabolism—POMC—hypothyroidism	1.54e-05	0.000125	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—AVP—hypothyroidism	1.53e-05	0.000124	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—PIK3C2A—hypothyroidism	1.53e-05	0.000124	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	1.51e-05	0.000122	CbGpPWpGaD
Norepinephrine—ADRA2C—Metabolism—POMC—hypothyroidism	1.5e-05	0.000121	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—POMC—hypothyroidism	1.49e-05	0.00012	CbGpPWpGaD
Norepinephrine—SLC22A1—Metabolism—POMC—hypothyroidism	1.44e-05	0.000116	CbGpPWpGaD
Norepinephrine—ADRA1D—Signaling Pathways—IGF1—hypothyroidism	1.43e-05	0.000116	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—POMC—hypothyroidism	1.36e-05	0.00011	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—POMC—hypothyroidism	1.34e-05	0.000109	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—POMC—hypothyroidism	1.33e-05	0.000107	CbGpPWpGaD
Norepinephrine—ADRB1—Signaling Pathways—IGF1—hypothyroidism	1.3e-05	0.000106	CbGpPWpGaD
Norepinephrine—ADRA2B—Signaling Pathways—IGF1—hypothyroidism	1.29e-05	0.000105	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—SLC5A5—hypothyroidism	1.29e-05	0.000104	CbGpPWpGaD
Norepinephrine—ADRB2—Signaling Pathways—IGF1—hypothyroidism	1.28e-05	0.000103	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—POMC—hypothyroidism	1.25e-05	0.000102	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—POMC—hypothyroidism	1.23e-05	0.0001	CbGpPWpGaD
Norepinephrine—ADRA2A—Metabolism—POMC—hypothyroidism	1.22e-05	9.87e-05	CbGpPWpGaD
Norepinephrine—ADRA2C—Signaling Pathways—IGF1—hypothyroidism	1.21e-05	9.77e-05	CbGpPWpGaD
Norepinephrine—ADRA1B—Signaling Pathways—IGF1—hypothyroidism	1.19e-05	9.62e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—POMC—hypothyroidism	1.14e-05	9.22e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—POMC—hypothyroidism	1.1e-05	8.88e-05	CbGpPWpGaD
Norepinephrine—DRD2—Signaling Pathways—IGF1—hypothyroidism	1.09e-05	8.87e-05	CbGpPWpGaD
Norepinephrine—ADRA1A—Signaling Pathways—IGF1—hypothyroidism	1.05e-05	8.54e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—POMC—hypothyroidism	1.02e-05	8.25e-05	CbGpPWpGaD
Norepinephrine—ADRA2A—Signaling Pathways—IGF1—hypothyroidism	9.8e-06	7.94e-05	CbGpPWpGaD
Norepinephrine—CYP1A2—Metabolism—POMC—hypothyroidism	6.73e-06	5.45e-05	CbGpPWpGaD
